MSI-H
Also known as: High-Frequency Microsatellite Instability / Microsatellite Instability-high (MSI-H) / High microsatellite instability / Microsatellite Instability-High / MSI-High / Microsatellite Instability High / Microsatellite Instability - High (MSI-H) / Microsatellite instability cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB09078 | Lenvatinib | A receptor tyrosine kinase inhibitor used for the treatment of metastatic thyroid cancer, advanced renal cell carcinoma in combination with everolimus, and unresectable hepatocellular carcinoma. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB17293 | Hiltonol | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Recruiting | 1 |
DB17480 | Nanrilkefusp alfa | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Completed | 1 |
DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
DB16413 | Sotigalimab | 1 | Completed | 1 |
DB15387 | Bintrafusp alfa | 1 / 2 | Active Not Recruiting | 1 |
DB16680 | Cadonilimab | 1 / 2 | Recruiting | 1 |
DB08935 | Obinutuzumab | 1 / 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 2 |
DB15765 | Sintilimab | 1 / 2 | Recruiting | 1 |
DB16680 | Cadonilimab | 2 | Not Yet Recruiting | 1 |
DB14776 | Camrelizumab | 2 | Active Not Recruiting | 1 |
DB00482 | Celecoxib | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
DB17743 | Fecal microbiota | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB14765 | Rivoceranib | 2 | Active Not Recruiting | 1 |
DB15043 | Toripalimab | 2 | Recruiting | 1 |
DB15765 | Sintilimab | 3 | Recruiting | 1 |
DB15769 | Envafolimab | Not Available | Not Yet Recruiting | 1 |